| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $809K | -6.3% | -11.4% |
| SG&A Expense | $1.1M | +29.2% | +31.7% |
| Operating Income | -$2.1M | -14.1% | -10.1% |
| Net Income | -$2.4M | -14.4% | -11.2% |
| EPS (Basic) | -$0.02 | +0.0% | +0.0% |
| EPS (Diluted) | -$0.02 | +0.0% | +0.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.7M | -11.1% | -62.2% |
| Current Assets | $1.8M | -9.6% | -61.0% |
| Total Assets | $2.0M | -8.8% | -57.9% |
| Current Liabilities | $47.1M | +4.4% | +17.2% |
| Stockholders' Equity | -$45.0M | -5.1% | -27.5% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.6M | — | — |
| Investing Cash Flow | -$5K | — | — |
| Financing Cash Flow | $3.3M | — | — |